Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 49 Records) |
| Query Trace: Disease and ELN[original query] |
|---|
| Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. Cancer management and research 2019 6 11 4129-4142. Huang Yan, Hu Juan, Lu Ting, Luo Yi, Shi Jimin, Wu Wenjun, Han Xiaoyan, Zheng Weiyan, He Jingsong, Cai Zhen, Wei Guoqing, Huang He, Sun J |
| Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Polish archives of internal medicine 2019 12 . Banescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Bogli? Alina, Lazar Erzsebet, Dima Delia, Macarie Ioan, Duicu Carmen, Iancu Mihae |
| Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia. Blood 2019 12 135 (8): 542-546. Fournier Elise, Duployez Nicolas, Ducourneau Benoît, Raffoux Emmanuel, Turlure Pascal, Caillot Denis, Thomas Xavier, Marceau-Renaut Alice, Chantepie Sylvain, Malfuson Jean-Valère, Lemasle Emilie, Cheok Meyling, Celli-Lebras Karine, Guerin Estelle, Terré Christine, Lambert Juliette, Pautas Cécile, Dombret Hervé, Castaigne Sylvie, Preudhomme Claude, Boissel Nicol |
| Atrial septal defects, supravalvular aortic stenosis and syndromes predisposing to aneurysm of large vessels. Acta bio-medica : Atenei Parmensis 2019 10 90 (10-S): 53-57. Baglivo Mirko, Dassati Sarah, Krasi Geraldo, Fanelli Francesca, Kurti Danjela, Bonelli Andrea, Arabia Gianmarco, Fabbicatore Davide, Muneretto Claudio, Bertelli Matt |
| Genetics of renovascular hypertension in children. Journal of hypertension 2020 Oct 38 (10): 1964-1970. Viering Daan H H M, Chan Melanie M Y, Hoogenboom Lieke, Iancu Daniela, de Baaij Jeroen H F, Tullus Kjell, Kleta Robert, Bockenhauer Detl |
| Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation. Blood advances 2020 Aug 4 (16): 3864-3874. Grimm Juliane, Jentzsch Madlen, Bill Marius, Goldmann Karoline, Schulz Julia, Niederwieser Dietger, Platzbecker Uwe, Schwind Sebasti |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemia. Blood advances 2021 9 5 (22): 4752-4761. Moser Christian, Jurinovic Vindi, Sagebiel-Kohler Sabine, Ksienzyk Bianka, Batcha Aarif M N, Dufour Annika, Schneider Stephanie, Rothenberg-Thurley Maja, Sauerland Cristina M, Görlich Dennis, Berdel Wolfgang E, Krug Utz, Mansmann Ulrich, Hiddemann Wolfgang, Braess Jan, Spiekermann Karsten, Greif Philipp A, Vosberg Sebastian, Metzeler Klaus H, Kumbrink Jörg, Herold Tobi |
| Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 2022 Aug . Lachowiez Curtis A, Reville Patrick K, Kantarjian Hagop, Jabbour Elias, Borthakur Gautam, Daver Naval, Issa Ghayas, Furudate Ken, Tanaka Tomoyuki, Pierce Sherry, Tang Guilin, Patel Keyur P, Medeiros Jeffrey, Abbas Hussein A, Haddad Fadi, Hammond Daniel, Short Nicholas J, Maiti Abhishek, Yilmaz Musa, Sasaki Koji, Takahashi Koichi, Pemmaraju Naveen, Konopleva Marina, Garcia-Manero Guillermo, Ravandi Farhad, Kadia Tapan M, Loghavi Sanam, DiNardo Courtney |
| Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 2022 12 12 (12): 170. Jentzsch Madlen, Bischof Lara, Ussmann Jule, Backhaus Donata, Brauer Dominic, Metzeler Klaus H, Merz Maximilian, Vucinic Vladan, Franke Georg-Nikolaus, Herling Marco, Platzbecker Uwe, Schwind Sebasti |
| Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia. Journal of internal medicine 2022 10 293 (3): 329-339. Weng Guangyang, Zhang Yu, Yu Guopan, Luo Tingyue, Yu Sijian, Xu Na, Sun Zhiqiang, Lin Dongjun, Deng Lan, Liang Xinquan, Xiao Jie, Zhang Hongyu, Guo Ziwen, Shao Ruoyang, Du Xin, Jin Hua, Liu Qi |
| Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 2022 1 97 (3): 329-337. Reville Patrick K, Sasaki Koji, Kantarjian Hagop M, Daver Naval G, Yilmaz Musa, Dinardo Courtney D, Short Nicholas J, Borthakur Gautam, Pemmaraju Naveen, Mehta Rohtesh S, Pierce Sherry, Konoplev Sergej N, Khoury Joseph D, Garcia-Manero Guillermo, Konopleva Marina Y, Jabbour Elias, Ravandi Farhad, Kadia Tapan |
High heritability of ascending aortic diameter and trans-ancestry prediction of thoracic aortic disease.
Nature genetics 2022 6 54 (6): 772-782. Tcheandjieu Catherine, Xiao Ke, Tejeda Helio, Lynch Julie A, Ruotsalainen Sanni, Bellomo Tiffany, Palnati Madhuri, Judy Renae, Klarin Derek, Kember Rachel L, Verma Shefali, , , , Palotie Aarno, Daly Mark, Ritchie Marylyn, Rader Daniel J, Rivas Manuel A, Assimes Themistocles, Tsao Philip, Damrauer Scott, Priest James |
| AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts. Leukemia research 2023 9 134 107376. Davidson Zhao, Qianghua Zhou, Mojgan Zarif, Entsar Eladl, Cuihong Wei, Eshetu G Atenafu, Andre Schuh, Anne Tierens, Yu Wing Tony Yeung, Mark D Minden, Hong Cha |
| Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification. Leukemia 2023 7 . Michael J Hochman, Megan Othus, Robert P Hasserjian, Alex Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elihu H Estey, Judith E Ka |
| Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa. Hematology/oncology and stem cell therapy 2023 6 16 (4): 397-406. Nicholas Jenkins, Lee-Ann Blanshard, Marian Stone, Estelle Verburgh, Jenna Oosthuizen, Karen Shir |
| UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia. Leukemia 2023 4 . Nicolas Duployez, Loïc Vasseur, Rathana Kim, Laëtitia Largeaud, Marie Passet, Anaïs L'Haridon, Pierre Lemaire, Laurène Fenwarth, Sandrine Geffroy, Nathalie Helevaut, Karine Celli-Lebras, Lionel Adès, Delphine Lebon, Céline Berthon, Alice Marceau-Renaut, Meyling Cheok, Juliette Lambert, Christian Récher, Emmanuel Raffoux, Jean-Baptiste Micol, Arnaud Pigneux, Claude Gardin, Eric Delabesse, Jean Soulier, Mathilde Hunault, Hervé Dombret, Raphael Itzykson, Emmanuelle Clappier, Claude Preudhom |
| Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia 2023 2 . Mrózek Krzysztof, Kohlschmidt Jessica, Blachly James S, Nicolet Deedra, Carroll Andrew J, Archer Kellie J, Mims Alice S, Larkin Karilyn T, Orwick Shelley, Oakes Christopher C, Kolitz Jonathan E, Powell Bayard L, Blum William G, Marcucci Guido, Baer Maria R, Uy Geoffrey L, Stock Wendy, Byrd John C, Eisfeld Ann-Kathr |
| The trace that is valuable: serum copper and copper to zinc ratio for survival prediction in younger patients with newly diagnosed acute myeloid leukaemia. BMC cancer 2023 1 23 (1): 14. Li Taotao, Shi Liming, Wei Wei, Xu Jiancheng, Liu Qiu |
| Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology 2023 1 7 e2200400. Cantu Miguel D, Kanagal-Shamanna Rashmi, Wang Sa A, Kadia Tapan, Bueso-Ramos Carlos E, Patel Sanjay S, Geyer Julia T, Tam Wayne, Madanat Yazan, Li Peng, George Tracy I, Nichols Meredith M, Rogers Heesun J, Liu Yen-Chun, Aggarwal Nidhi, Kurzer Jason H, Maracaja Danielle L V, Hsi Eric D, Zaiem Feras, Babu Daniel, Foucar Kathryn, Laczko Dorottya, Bagg Adam, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga |
| Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples. International journal of hematology 2024 9 . Hiroyuki Sugiura, Tatsunori Ishikawa, Taiga Kuroi, Sachiyo Okamoto, Naho Nomura, Taro Masunari, Nobuo Sezaki, Seishi Ogawa, Yasuhito Nannya, Masanori Maki |
| The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study. Leukemia & lymphoma 2024 8 1-10. Deyuan Hu, Kai Shen, YuSha Guo, Xie Bing Bao, Ningzheng Dong, Suning Ch |
| T315I - a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia. Advances in laboratory medicine 2024 12 5 (4): 412-417. Bushra Kaleem, Sadaf Shahab, Tahir Sultan Sham |
| Genetic Etiology Investigation in Treatment-Resistant Nocturnal Enuresis Children: A descriptive study. Urology journal 2024 12 . Sevim Yener, Metin Es |
| Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 11 . Guopan Yu, Yu Zhang, Sijian Yu, Zhao Yin, Guangyang Weng, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Zhiping Fan, Li Xuan, Hui Liu, Dan Xu, Jieyu Ye, Xuejie Jiang, Pengcheng Shi, Hua Jin, Qifa L |
| [Diagnosis and Risk Stratification of Acute Myeloid Leukemia, Myelodysplasia -Related]. Zhongguo shi yan xue ye xue za zhi 2024 10 32 (5): 1372-1376. Hui Yang, Rui Guo, Yu Shi, Chun Qiao, Yan Wang, Yu-Jie Wu, Hai-Rong Q |
| Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
| Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances 2024 1 . Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lanc |
| Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 2024 1 14 (1): 15. Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Ti |
| Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML. HemaSphere 2025 1 9 (1): e70060. Sibylle Cocciardi, Maral Saadati, Nina Weiß, Daniela Späth, Silke Kapp-Schwoerer, Isabelle Schneider, Annika Meid, Verena I Gaidzik, Sabrina Skambraks, Walter Fiedler, Michael W M Kühn, Ulrich Germing, Karin T Mayer, Michael Lübbert, Elli Papaemmanuil, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Axel Benner, Hartmut Döhner, Konstanze Döhn |
- Page last reviewed:Feb 1, 2024
- Content source: